Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.18 USD | -0.62% | -12.40% | -5.92% |
Financials (USD)
Sales 2024 * | - | Sales 2025 * | 329K | Capitalization | 120M |
---|---|---|---|---|---|
Net income 2024 * | -86M | Net income 2025 * | -105M | EV / Sales 2024 * | - |
Net cash position 2024 * | 113M | Net cash position 2025 * | 241M | EV / Sales 2025 * | -369 x |
P/E ratio 2024 * |
-1.66
x | P/E ratio 2025 * |
-1.65
x | Employees | 65 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 90.79% |
Latest transcript on Vigil Neuroscience, Inc.
1 day | -0.63% | ||
1 week | -12.40% | ||
1 month | +21.84% | ||
3 months | -8.62% | ||
Current year | -5.92% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 55 | 20-06-30 | |
Director of Finance/CFO | 50 | 20-06-30 | |
Kelly Neelon
CTO | Chief Tech/Sci/R&D Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 55 | 20-06-30 | |
Mary Thistle
BRD | Director/Board Member | 64 | 22-04-17 |
Cheryl Blanchard
BRD | Director/Board Member | 59 | 20-10-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.00% | 34 M€ | +3.86% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-31 | 3.18 | -0.63% | 120,814 |
24-05-30 | 3.2 | +7.74% | 38,816 |
24-05-29 | 2.97 | -10.27% | 94,663 |
24-05-28 | 3.31 | -8.82% | 203,497 |
24-05-24 | 3.63 | +1.11% | 58,138 |
Delayed Quote Nasdaq, May 31, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-5.92% | 120M | |
+43.36% | 54.64B | |
-5.31% | 39.92B | |
+37.52% | 38.82B | |
+14.75% | 26.86B | |
-12.56% | 26.22B | |
-22.45% | 18.78B | |
+0.04% | 12.16B | |
+25.12% | 12.21B | |
+26.04% | 11.94B |
- Stock Market
- Equities
- VIGL Stock